Synaptogenix Inc (SNPX)

[Cyosol]

I'd say fundraising, starting trials, and announcing results are what I would consider major events at this stage. Announcing a partnership would be huge too. First dosing though? I don't see what we as shareholders will get out of that except a pretty little press release that ultimately does nothing to the stock price.

Don't get me wrong, I very much appreciate the company making progress in different directions, it's just that some of these news are not exactly very important. One way or another, we know that at some point patients will be dosed.

You're right about the published phase 2 data though. That one will be exciting to read. Hopefully we'll know soon when the Fragile X study finishes too.